Does ibuprofen block the cardioprotective effects of aspirin in dental patients?

General Dentistry

Volumn 54, Issue 1, 2006, Pages 6-9

  Wynn, Richard L ^a   Cook, Jerry ^b  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; THROMBOXANE B2;

BLOOD; CORONARY ARTERY THROMBOSIS; DRUG ANTAGONISM; HUMAN; SHORT SURVEY; THROMBOEMBOLISM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CORONARY THROMBOSIS; DRUG ANTAGONISM; HUMANS; IBUPROFEN; INTRACRANIAL EMBOLISM AND THROMBOSIS; PLATELET AGGREGATION INHIBITORS; THROMBOXANE B2;

EID: 33144478252     PISSN: 03636771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (13)

1. Hambleton J, O'Reilly RA. Drugs used in disorders of coagulation. In: Katzung BG, ed. Basic and clinical pharmacology, ed. 8. New York: McGraw-Hill Medical;2000:564-580.
2. Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, Vyas SN, FitzGerald GA. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Eng J Med 2001;345:1809-1817.
3. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999;340:1888-1899.
4. Crofford LJ. Rational use of analgesic an anti-inflammatory drugs. N Eng J Med 2001;345:1844-1846.
5. MacDonald TM, Wei L. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet 2003;361:573-574.
6. Evans JM, MacDonald TM. Record-linkage for pharmacovigilance in Scotland. Br J Clin Pharmacol 1999;47;105-110.
7. Umar A, Boisseau M, Yusup A, Upur H, Begaud B, Moore N. Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model. Fundam Clin Pharmacol 2004;18:559-563.
8. Kurth T, Glynn RJ, Walker AM, Chan KA, Buring JE, Hennekens CH, Gaziano JM. Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation 2003;108:1191-1195.
9. Curtis JP, Wang Y, Portnay EL, Masoudi FA, Havranek EP, Krumholz HM. Aspirin, ibuprofen, and mortality after myocardial infarction: Retrospective cohort study. BMJ 2003;327:1322-1323.
10. Cheema AA. Should people on aspirin avoid ibuprofen? A review of the literature. Cardiol Rev 2004;12:174-176.
11. Patel TN, Goldberg KC. Use of aspirin and ibuprofen compared with aspirin alone and the risk of myocardial infarction. Arch Intern Med 2004;164:852-856.
12. Cryer B, Berlin RG, Cooper SA, Hsu C, Wason S. Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers. Clin Ther 2005;27:185-191.
13. Corman SL, Fedutes BA, Ansani NT. Impact of nonsteroidal antiinflammatory drugs on the cardioprotective effects of aspirin. Ann Pharmacother 2005;39:1073-1079.